BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 12768272)

  • 1. Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
    Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M
    Psychopharmacology (Berl); 2003 Oct; 170(1):80-8. PubMed ID: 12768272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
    Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M
    Jpn J Pharmacol; 2002 Apr; 88(4):399-406. PubMed ID: 12046982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence.
    Jin C; Araki H; Nagata M; Shimosaka R; Shibata K; Suemaru K; Kawasaki H; Gomita Y
    Behav Brain Res; 2005 Jun; 161(1):107-12. PubMed ID: 15904717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noradrenergic and corticosteroid receptors regulate somatic and motivational symptoms of morphine withdrawal.
    Solecki WB; Kus N; Gralec K; Klasa A; Pradel K; Przewłocki R
    Behav Brain Res; 2019 Mar; 360():146-157. PubMed ID: 30500430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the bed nucleus of the stria terminalis activated by the central nucleus of the amygdala in the negative affective component of morphine withdrawal in rats.
    Nakagawa T; Yamamoto R; Fujio M; Suzuki Y; Minami M; Satoh M; Kaneko S
    Neuroscience; 2005; 134(1):9-19. PubMed ID: 15939543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the effects of clonidine and CNQX infusion into the locus coeruleus and the amygdala on naloxone-precipitated opiate withdrawal in the rat.
    Taylor JR; Punch LJ; Elsworth JD
    Psychopharmacology (Berl); 1998 Jul; 138(2):133-42. PubMed ID: 9718282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α7 Nicotinic acetylcholine receptors in the central amygdaloid nucleus alter naloxone-induced withdrawal following a single exposure to morphine.
    Ishida S; Kawasaki Y; Araki H; Asanuma M; Matsunaga H; Sendo T; Kawasaki H; Gomita Y; Kitamura Y
    Psychopharmacology (Berl); 2011 Apr; 214(4):923-31. PubMed ID: 21125398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of beta-adrenergic receptor antagonism in basolateral amygdala on reconsolidation of aversive and appetitive memories associated with morphine in rats.
    Wu Y; Li Y; Yang X; Sui N
    Addict Biol; 2014 Jan; 19(1):5-15. PubMed ID: 22458530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawal-induced c-Fos expression in the rat centromedial amygdala 24 h following a single morphine exposure.
    Jin C; Araki H; Nagata M; Suemaru K; Shibata K; Kawasaki H; Hamamura T; Gomita Y
    Psychopharmacology (Berl); 2004 Oct; 175(4):428-35. PubMed ID: 15175841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The glutamate release inhibitor riluzole attenuates the formation of conditioned place aversion induced by naloxone in rats undergoing a single morphine exposure.
    Jin C; Araki H; Kawasaki Y; Nagata M; Suemaru K; Shibata K; Hamamura T; Kawasaki H; Gomita Y
    Brain Res; 2006 Jan; 1069(1):120-6. PubMed ID: 16360647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Involvement of the amygdala on place aversion induced by naloxone in single-dose morphine-treated rats].
    Ishida S; Shimosaka R; Kawasaki Y; Jin C; Kitamura Y; Araki H; Sendo T; Gomita Y
    Yakugaku Zasshi; 2008 Mar; 128(3):395-403. PubMed ID: 18311059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CB₁ receptor antagonism in the bed nucleus of the stria terminalis interferes with affective opioid withdrawal in rats.
    Wills KL; DeVuono MV; Limebeer CL; Vemuri K; Makriyannis A; Parker LA
    Behav Neurosci; 2017 Aug; 131(4):304-11. PubMed ID: 28714716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of excitotoxic lesions of the central or basolateral nucleus of the amygdala on naloxone-precipitated withdrawal-induced conditioned place aversion in morphine-dependent rats.
    Watanabe T; Yamamoto R; Maeda A; Nakagawa T; Minami M; Satoh M
    Brain Res; 2002 Dec; 958(2):423-8. PubMed ID: 12470879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal.
    Azar MR; Jones BC; Schulteis G
    Psychopharmacology (Berl); 2003 Oct; 170(1):42-50. PubMed ID: 12783156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta1 adrenergic receptors in the bed nucleus of stria terminalis mediate differential responses to opiate withdrawal.
    Cecchi M; Capriles N; Watson SJ; Akil H
    Neuropsychopharmacology; 2007 Mar; 32(3):589-99. PubMed ID: 16823388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development, extinction and reinstatement of morphine withdrawal-induced conditioned place aversion in rats.
    Li Y; Liu X; Chen H; Deng H; Xiang X; Chen H; Hao W
    Addict Biol; 2007 Sep; 12(3-4):470-7. PubMed ID: 17678507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-adrenergic antagonists attenuate somatic and aversive signs of opiate withdrawal.
    Harris GC; Aston-Jones G
    Neuropsychopharmacology; 1993 Dec; 9(4):303-11. PubMed ID: 7905738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal.
    Frenois F; Cador M; Caillé S; Stinus L; Le Moine C
    Eur J Neurosci; 2002 Oct; 16(7):1377-89. PubMed ID: 12405997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal.
    Caillé S; Espejo EF; Reneric JP; Cador M; Koob GF; Stinus L
    J Pharmacol Exp Ther; 1999 Aug; 290(2):881-92. PubMed ID: 10411605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
    Stinus L; Cador M; Zorrilla EP; Koob GF
    Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.